Carlsbad, CA – Artis BioSolutions has announced the appointment of Kate Broderick as Chief Scientific Innovation Officer. About Artis BioSolutions: Artis BioSolutions is a San Diego-based platform company dedicated to developing and manufacturing advanced therapies. The company aims to build and scale differentiated capabilities to support the entire lifecycle of advanced therapeutic programs. With a growing global presence, including Landmark Bio in Boston, Artis BioSolutions collaborates with biotech and pharmaceutical companies to provide integrated solutions. The company is strategically expanding its leadership and scientific capabilities, notably with the appointment of Dr. Kate Broderick as Chief Scientific Innovation Officer, to accelerate innovation in nucleic acid medicines. This move, alongside the pending acquisition of Syngoi Technologies, strengthens Artis’s focus on synthetic DNA strategy and its mission to create an integrated ecosystem for next-generation genetic medicines.

For more information on Artis BioSolutions please visit: https://artisbiosolutions.com/

Artis BioSolutions
Address Unavailable
Carlsbad, CA 92010
Phone:
LinkedIn Page: https://www.linkedin.com/company/artis-biosolutions/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved